Neutral
GlobeNewsWire
25 days ago
American Shared Hospital Services Reports First Quarter 2026 Financial Results
15.9% Revenue Growth Driven by Direct Patient Services Expansion; Operating Performance Improves Year-Over-Year Gross Margins Increased 36.7% Year-Over-Year Adjusted EBITDA Increased 18.4% Year-Over-Year Volumes Continuing to Trend Higher into the Second Quarter Conference Call Scheduled for 12:00 PM ET Today SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, today announced financial results for the first quarter ended March 31, 2026. Key Financial Highlights Total revenue: $7.1 million, compared with $6.1 million in the first quarter of 2025, an increase of 15.9% Gross margin: Increased 36.7% to $1.3 million, or 18.2%, compared with $0.9 million, or 15.4%, in the prior year period Operating loss: Improved to $(0.9) million, compared with $(1.3) million in the prior year period Net loss attributable to American Shared Hospital Services: $(0.6) million, compared with $(0.6) million in the prior year period Adjusted EBITDA: Increased 18.4% to $1.1 million compared to $0.9 million in the prior year period Direct patient services revenue: Increased 30.2% to $4.1 million, compared with $3.1 million in the prior year period Leasing revenue: $3.0 million, compared with $3.0 million in the prior year period Operational Highlights Gamma Knife procedures increased 10.1% year-over-year, with 229 procedures performed PBRT treatments increased 20.7% year-over-year to 1,003 Rhode Island centers continued to ramp up utilization Puebla center continued strong growth driven by improved reimbursement and operational ramp up Segment Performance Direct Patient Care Services Revenue from direct patient services increased 30.2% to approximately $4.1 million in the first quarter of 2026 from $3.1 million in the prior year period, driven by contributions from the Company's three Rhode Island radiation therapy centers and its Puebla, Mexico facility.
